Gordon, K.B., Langley, R.G., Warren, R.B., Okubo, Y., Rosmarin, D., Lebwohl, M., Peterson, L., Madden, C., de Cuyper, D., Gomez, N.N. and Thaçi, D. 2022. Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s66. DOI:https://doi.org/10.25251/skin.6.supp.66.